Top Story

No differences in CDI-related complications between toxin-positive and NAAT-positive-only CDI

January 19, 2019

Trial testing FMT for recurrent diarrheal disease begins

January 19, 2019
A research consortium across multiple institutions has begun enrolling patients in a clinical trial examining whether fecal microbiota transplantation by enema is safe…
In the Journals

Crohn’s duration linked to Entyvio response

January 18, 2019
Patients who have Crohn’s disease for two years or less are more likely to experience complete and endoscopic response with Entyvio, according to research…
FDA News

Government shutdown threatens biosimilar approvals, patent litigation

January 18, 2019
As the ongoing partial government shutdown continues in the United States, the FDA has approximately 5 weeks until drug user fees completely dry up, jeopardizing the…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 24: A 65-Year-Old Male On Plavix Following A Recent Mi And Coronary Stenting Was Seen In The Er With Fever, Pain, Jaundice, And A Wbc Of 18,000. Us Showed A Dilated Bile Duct Of 15 Mm And A Gallbladder Full Of Stones. Mrcp Revealed A 15-Mm Stone In The Distal Cbd. What Would You Do?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Resource Centers
Meeting News

VIDEO: Gilead reports phase 2 safety, efficacy of GS-9674 for NASH

November 27, 2018
More »